Fact CheckerSign in

NCT04317417Completed

MOST EMPOWER: Optimizing An Emotion Regulation Intervention

Using MOST to EMPOWER: Optimizing an Emotion Regulation Intervention to Enhance Well-being Among Adolescents and Young Adult Cancer Survivors

Source: ClinicalTrials.gov · Last updated 9 Jul 2026

Brief summary (registry, in English)

This purpose of this study is to test a digital health intervention that may promote well-being among young adult cancer survivors. Investigators hope to learn more about wellness and health-related quality of life among young adult cancer survivors by promoting well-being and teaching skills for healthy coping and mood management.

Status (registry)
Completed
Study type
Interventional
Enrollment
352 (actual)
First submitted
19 Mar 2020
Start date
6 Jan 2022
Primary completion date
30 Apr 2025
Lead sponsor
Wake Forest University Health Sciences
NCT number
NCT04317417

What you commit to

  • Study type: Interventional
  • Participants enrolled: 352
  • From 6 Jan 2022 to the primary completion date, 30 Apr 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently receiving palliative or hospice care

Other illness

  • Ever been hospitalized for a psychiatric illness

Who the study is looking for

  • Able to read and understand English
  • Past history of a cancer diagnosis (excluding basal cell skin carcinoma)
  • 15 to 39 years of age at diagnosis of first cancer and currently between the ages of 15 to 39
  • Within 0-5 year's post-active treatment for initial diagnosis or recurrence (Note: Maintenance therapy for hematologic or hormonal therapy for breast cancers are not considered "active treatments" for purposes of this study).
  • Internet access through a home computer, tablet or smartphone.

Age in the registry: 15 years to 39 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Northwestern University Feinberg School of Medicine
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status
MD Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
Wake Forest Baptist Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Winston-SalemUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.